Inhibition of Cyclin-Dependent Kinase 9 Downregulates Cytokine Production Without Detrimentally Affecting Human Monocyte-Derived Macrophage Viability
Cyclin-dependent kinase (CDK) inhibitor drugs (CDKi), such as R-roscovitine and AT7519, induce neutrophil apoptosis in vitro and enhance the resolution of inflammation in a number of in vivo models. This class of compounds are potential novel therapeutic agents that could promote the resolution of a...
Main Authors: | Brian J. McHugh, Jillian Stephen, Calum T. Robb, Sarah Fox, Tiina Kipari, Jennifer A. Cartwright, Christopher Haslett, Rodger Duffin, Christopher D. Lucas, Adriano G. Rossi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.905315/full |
Similar Items
-
Coming of Age: Targeting Cyclin K in Cancers
by: Yi Xiao, et al.
Published: (2023-08-01) -
D-Type Cyclins in Development and Disease
by: Mostafa Saleban, et al.
Published: (2023-07-01) -
The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
by: Aadil Javed, et al.
Published: (2023-02-01) -
The Less Known Cyclins—Uncovered
by: Agnieszka Żuryń, et al.
Published: (2021-03-01) -
Consequence of the tumor‐associated conversion to cyclin D1b
by: Michael A Augello, et al.
Published: (2015-05-01)